发明名称 |
INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER |
摘要 |
Integrin interaction inhibitors using a beta-turn promoter are described herein. These peptides are useful in treating cancer, such as multiple myeloma, by administering a therapeutically effective amount of the integrin interaction inhibitor. Data show that integrin interaction inhibitors act synergistically or additively interact with anti-proliferative agents such as doxorubicin, SAHA, arsenic trioxide, and etoposide. |
申请公布号 |
EP2547693(A2) |
申请公布日期 |
2013.01.23 |
申请号 |
EP20110756673 |
申请日期 |
2011.03.21 |
申请人 |
H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE;UNIVERSITY OF SOUTH FLORIDA |
发明人 |
HAZLEHURST, LORI;MCLAUGHLIN, MARK;JAIN, PRIYESH;DALTON, WILLIAM, S. |
分类号 |
C07K7/06;A61K38/00 |
主分类号 |
C07K7/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|